Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 0.919 | 37 | 4 | 1978 | 2019 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.100 | None | 0.917 | 36 | 0 | 1989 | 2019 | |||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.400 | None | 0.912 | 34 | 0 | 1991 | 2019 | ||||||||
|
TNF receptor superfamily member 1A | 0.409 | 0.923 | 0.99 |
|
disease | 0.500 | None | 0.970 | 33 | 4 | 1999 | 2019 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
disease | 0.100 | None | 0.839 | 31 | 1 | 1997 | 2019 | ||||||||
|
neurofilament light | 0.488 | 0.769 |
|
disease | 0.100 | None | 0.968 | 31 | 0 | 2004 | 2020 | |||||||||
|
major histocompatibility complex, class II, DR beta 5 | 0.608 | 0.731 | 3.6E-07 |
|
disease | 0.100 | None | 0.967 | 30 | 0 | 1976 | 2019 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.100 | None | 0.967 | 30 | 2 | 1990 | 2019 | ||||||||
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
disease | 0.500 | None | 1.000 | 29 | 16 | 2009 | 2020 | ||||||||
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
disease | 0.100 | None | 0.929 | 28 | 3 | 1994 | 2020 | ||||||||
|
interferon stimulated exonuclease gene 20 | 0.414 | 0.846 | 2.9E-03 |
|
disease | 0.100 | None | 1.000 | 27 | 0 | 1994 | 2019 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 1999 | 2019 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 1999 | 2019 | |||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.100 | None | 0.885 | 26 | 0 | 2001 | 2019 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.400 | None | 0.880 | 25 | 0 | 1990 | 2018 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
disease | 0.100 | None | 0.875 | 24 | 2 | 1997 | 2019 | ||||||||
|
forkhead box P3 | 0.368 | 0.846 | 0.99 |
|
disease | 0.100 | None | 1.000 | 24 | 3 | 2005 | 2019 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.500 | None | 0.958 | 24 | 2 | 2000 | 2019 | ||||||||
|
CD58 molecule | 0.584 | 0.769 | 0.25 |
|
disease | 0.500 | None | 1.000 | 24 | 5 | 2008 | 2019 | ||||||||
|
cytochrome P450 family 27 subfamily B member 1 | 0.502 | 0.769 | 1.9E-07 |
|
disease | 0.200 | None | 0.905 | 21 | 2 | 2008 | 2019 | ||||||||
|
endogenous retrovirus group W member 1, envelope | 0.505 | 0.692 |
|
disease | 0.100 | None | 1.000 | 20 | 0 | 2004 | 2019 | |||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.100 | None | 0.850 | 20 | 0 | 1998 | 2019 | ||||||||
|
membrane bound transcription factor peptidase, site 1 | 0.532 | 0.692 | 7.6E-09 |
|
disease | 0.100 | None | 1.000 | 20 | 0 | 2007 | 2020 | ||||||||
|
interleukin 7 | 0.464 | 0.808 | 0.93 |
|
disease | 0.400 | None | 0.947 | 19 | 0 | 2007 | 2018 | ||||||||
|
interleukin 23 subunit alpha | 0.415 | 0.846 | 0.36 |
|
disease | 0.100 | None | 0.947 | 19 | 0 | 2006 | 2019 |